Envoy Therapeutics Articles
Torrey Pines Institute collaborates with Takeda unit
28 January 2013
Takeda in schizophrenia research alliance with Envoy Thera
11 October 2010
Showing 1-3 of 3 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
